SCHEMBL493849

SCHEMBL493849

COc1ccc(S(=O)(=O)N(C)CCOCC(=O)NCCC2CCC(C(c3ccc(Cl)cc3)N(C)C)CC2)cc1OC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
KMT2A Q03164 3/20 0.38
GAA P10253 2/20 0.38
MAPT P10636 2/20 0.37
TSHR P16473 1/20 0.37
PTGER1 P34995 1/20 0.37
PKM P14618 1/20 0.37
RAB9A P51151 2/20 0.36
NR2F2 P24468 1/20 0.36
BDKRB1 P46663 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MEN1 O00255 1/20 0.36
HSD17B10 Q99714 1/20 0.36
LMNA P02545 1/20 0.35
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL492854 0.93 ALDH1A1 (0.41) ALDH1A1KMT2AGAAMAPTTSHR
SCHEMBL492548 0.93 ALDH1A1 (0.39) ALDH1A1KMT2AGAAMAPTTSHR
SCHEMBL493432 0.92 ALDH1A1 (0.38) ALDH1A1KMT2AGAAPKMBDKRB1
SCHEMBL493385 0.90 SMN1; SMN2 (0.43) ALDH1A1KMT2AMAPTBDKRB1SMN1; SMN2
SCHEMBL492990 0.89 UTS2R (0.36) ALDH1A1KMT2AGAAPTGER1BDKRB1
SCHEMBL493206 0.88 KMT2A (0.37) ALDH1A1KMT2AMAPTHTTSMN1; SMN2
SCHEMBL493053 0.88 KMT2A (0.37) ALDH1A1KMT2AMAPTHTTSMN1; SMN2
SCHEMBL493349 0.88 ALDH1A1 (0.40) ALDH1A1KMT2AGAAMAPTTSHR
SCHEMBL493207 0.86 BDKRB1 (0.42) BDKRB1
SCHEMBL493353 0.86 BDKRB1 (0.52) BDKRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8106055-B2 Substituted amide compounds GRUENENTHAL GMBH (DE) 2012-01-31 US claimed
EP-2139851-A2 SUBSTITUTED AMIDE DERIVATIVES Grünenthal GmbH (DE) 2010-01-06 EP claimed
US-20080306084-A1 Substituted Amide Compounds GRUENENTHAL GMBH (DE) 2008-12-11 US claimed
WO-2008131946-A2 SUBSTITUTED AMIDE DERIVATIVES Grünenthal GmbH (DE) 2008-11-06 WO claimed
US-8106055-B2 Substituted amide compounds GRUENENTHAL GMBH (DE) 2012-01-31 US disclosed
US-20080306084-A1 Substituted Amide Compounds GRUENENTHAL GMBH (DE) 2008-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306084-A1 Substituted Amide Compounds OPRK1, NAA50, ACMSD ALDH1A1 1349/4885KMT2A 1749/4885GAA 445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.